National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/12/2021 release of VAERS data:

Found 203 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 14 out of 21

Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next


VAERS ID: 1550168 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Male  
Location: Kentucky  
Vaccinated:2021-03-31
Onset:2021-04-01
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-08-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808980 / 1 RA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Asthenia, Eye disorder, Fatigue, Feeling jittery, Formication, Guillain-Barre syndrome, Hypoaesthesia, Joint stiffness, Mobility decreased, Muscle spasms, Paraesthesia, Throat tightness
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Peripheral neuropathy (narrow), Dystonia (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Corneal disorders (broad), Retinal disorders (broad), Hypersensitivity (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Ginkgo Biloba
Current Illness: No
Preexisting Conditions: No
Allergies: No
Diagnostic Lab Data: To summarize a lengthy report, Dr. , stated the findings are difficult to interrupt, they most closely correspond to an Acute Inflammatory Demyelinating Polyradiculoneuropathic presentation. (aka Guillain-Barre Syndrom)
CDC Split Type:

Write-up: Major numbness and tingling in both feet. Toes are tight and hard to bend. Hands have periodic sharp pains to go through. Weakness and fatigue and jittery feeling in legs. Pressure at the bottom of throat which is worse while lying down. Bug crawling sensation over body, but mainly in the legs. Muscle spasms and cramping. Eyes feel like you are looking out a fish bowl. After 30 days the entire body got extremely tight and hard to bend, hard to wash feet.


VAERS ID: 1559245 (history)  
Form: Version 2.0  
Age: 54.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-08-09
Onset:2021-08-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN NDC: 59676-580- / 1 RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Lymphadenopathy, Pain in extremity, Paraesthesia, Tongue disorder
SMQs:, Peripheral neuropathy (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: carvedilol 6.25mg twice daily
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: No tests and no doctor or medical facility visited as of today 8/14/21. I have an appointment scheduled with my primary care physician on Tuesday August 17th and I plan to bring up my suspicion of GUILLAIN-BARRE SYNDROME
CDC Split Type:

Write-up: Suspected case of GUILLAIN-BARRE SYNDROME: Received the jab 5 days ago on 8/9/21 - two hours after receiving the injection to the right arm my face numbed up with tingling especially pronounced in the jaw and thick tongue felt similar to the numbing effect after a dentist appointment. Awkward trying to move my jaw around. Face tingling was worst the first day and symptoms were more mild the next day regarding tingling in the face but have been consistent and ever present. 8/11 numbness in legs after a long walk. Today 8/14 tingling/numbness continues in the face and the lymph nodes behind my jaw are swollen and today observed numbness and pain in both legs pain is a rated a 3 out of 10 with 10 being most severe


VAERS ID: 1569185 (history)  
Form: Version 2.0  
Age: 44.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-04-07
Onset:2021-04-27
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-08-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / 1 LA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Bell's palsy, Blood test, Bradykinesia, Dizziness, Electromyogram abnormal, Facial paresis, Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia oral, Mobility decreased, Muscular weakness, Pain of skin, Pyrexia, SARS-CoV-2 test negative, Sensitive skin, Tremor
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Parkinson-like events (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Vestibular disorders (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Doxycycline
Diagnostic Lab Data: COVID-19 negative (6/2), EMG positive (7/21), blood lab work numerous times between 4/27 and 7/21.
CDC Split Type:

Write-up: Diagnosed with Bell''s Palsy on 4/27/21 with symptoms of weakening of muscles on left side of face and numbness of tongue. Recovered from Bell''s Palsy within 3 weeks. High fever on 6/2/21 with muscle weakness, skin sensitivity to touch, tremors in hands and legs and light headedness. Seen at emergency on 6/2 and received negative COVID-19 test. Recovered from all symptoms except light headeness and muscle weakness in legs. Referred to neurologist. Received EMG test on 7/21 and diagnosed with Guillain-Barre. Muscle weakness in legs persists to present day as does light headedness. Mobility is significant reduced. Can still walk but it is difficult to climb stairs and walking speed is about 30-50% normal speed.


VAERS ID: 1574284 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-04-09
Onset:2021-04-30
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-08-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 042A21A / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Dialysis, Diplegia, Dysstasia, Endotracheal intubation, Guillain-Barre syndrome, Speech disorder
SMQs:, Acute renal failure (narrow), Angioedema (broad), Peripheral neuropathy (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Chronic kidney disease (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 95 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Diabetic.
Allergies: None.
Diagnostic Lab Data:
CDC Split Type:

Write-up: Paralysis started in feet, hands, legs. Weak, unable to stand on own, speech is off, was diagnosed with Guillian-Barre syndrome , has went through 5 treatments of dialysis, intubated 3 times, and 30 days of therapy.


VAERS ID: 1575102 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Female  
Location: Nevada  
Vaccinated:2021-04-11
Onset:2021-04-01
Submitted: 0000-00-00
Entered: 2021-08-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 042A21A / 1 RA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Anger, Arthralgia, Arthropathy, Autoimmune disorder, Blood test abnormal, Guillain-Barre syndrome, Joint noise, Lichen sclerosus, Musculoskeletal stiffness
SMQs:, Peripheral neuropathy (narrow), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Hostility/aggression (narrow), Demyelination (narrow), Arthritis (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Multiple vitamin
Current Illness: NONE
Preexisting Conditions: NONE
Allergies: Sulpha drugs
Diagnostic Lab Data: Dr appointment with Dr 07/13/21 10:00 AM. Blood work 07/21/21 9:00 AM. Dr Appointment 08/09/21 10:00 AM. Referral to Neurologist on 08/09/21. Waiting for neurologist office to contact me with appointment date/time.
CDC Split Type:

Write-up: I had painful aches in my joints, which led way to stiffness and popping and creaking like all the fluid was sucked out. I shortly developed Lichen Sclerosis and was diagnosed by my doctor and given medication. My blood work now shows autoimmune! I have Guillain Barre also! And I?m angry and want some answers! I was healthy!


VAERS ID: 1578194 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Female  
Location: New Mexico  
Vaccinated:2021-07-02
Onset:2021-07-02
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / N/A RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Constipation, Diverticulitis, Facial paralysis, Fatigue, Guillain-Barre syndrome, Hypoaesthesia, Ileus paralytic, Neuropathy peripheral, Pain, Pain in extremity, Reflexes abnormal
SMQs:, Acute pancreatitis (broad), Peripheral neuropathy (narrow), Gastrointestinal obstruction (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific inflammation (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Hearing impairment (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: levothyroxine, B12, Vit D, fish oil, benedryl
Current Illness: none
Preexisting Conditions: pemphigus foleacious and fibromyalgia
Allergies: none relevant
Diagnostic Lab Data: Hospitalization, bilateral facial paralysis, severe peripheral neuropathy, numbness, paralysis of intestinal tract resulting in 9 days of inability to have a bowel movement resulting in diverticulitis, burning searing pain in hands and feet, loss of reflexes. exhaustion.
CDC Split Type:

Write-up: Guillain Barre Syndrome - Johnson&Johnson


VAERS ID: 1594338 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Massachusetts  
Vaccinated:0000-00-00
Onset:2021-04-22
Submitted: 0000-00-00
Entered: 2021-08-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 042A21A / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Electromyogram, Guillain-Barre syndrome, Hypoaesthesia, Inflammation, Loss of personal independence in daily activities, Lumbar puncture, Magnetic resonance imaging, SARS-CoV-2 test
SMQs:, Peripheral neuropathy (narrow), Dementia (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Alcohol use (once daily); Cannabis abuse, unspecified use (occasional); Non-smoker (occasionally (once a year, cigar celebration)); Comments: No known drug allergies, previously active lifestyle (exercise, played sports)
Allergies:
Diagnostic Lab Data: Test Name: Magnetic resonance imaging; Result Unstructured Data: diagnosed with Guillain-Barre syndrome; Test Name: Lumbar puncture; Result Unstructured Data: diagnosed with Guillain-Barre syndrome; Test Name: COVID-19 virus test; Result Unstructured Data: negative; Test Name: EMG; Result Unstructured Data: not reported; Comments: to see extent of prevalent damage in his left leg; Test Name: EMG; Result Unstructured Data: not reported; Test Name: Lumbar puncture; Result Unstructured Data: elevated proteins
CDC Split Type: USJNJFOC20210830495

Write-up: WEAKNESS; UNABLE TO FUNCTION; NUMBNESS IN HANDS AND FEET; MIDSECTION (WAIST) WAS NUMB; LINGERING INFLAMMATION; GUILLAIN BARRE SYNDROME; Initial information was processed with additional information received on 16-AUG-2021 from the patient via a telephone communication log (TCL). This spontaneous report received from a patient concerned a 58 year old white male. The patient''s height, and weight were not reported. The patient''s concurrent conditions included: alcohol use (once daily), non-smoker (occasional once a year, cigar celebration), and occasional cannabis edible consumption. He had a previously active lifestyle (exercise, played sports). Patient did not had any known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 19-SEP-2021) on 03-APR-2021 11:00 into left arm, for prophylactic vaccination. No concomitant medications were reported. Patient reported that on 22-APR-2021, he developed Guillain Barre Syndrome (GBS) two weeks post-vaccination, and was hospitalized. His symptoms included numb mid-section of torso ("felt like wearing a tick and wide belt"), fingertip numbness, aching feeling all over the torso and legs, "ants under skin" feeling, and facial palsy. The symptoms gradually spread and worsened over time with bilateral weakness and urinary urgency. COVID-19 virus test on an unspecified date was negative. Patient went to the medical center to figure out the symptoms he was experiencing. He was admitted on 22-APR-2021. Did all the tests, magnetic resonance imaging (MRI) and lumbar puncture. Patient was diagnosed with Guillain Barre Syndrome (GBS). Patient was treated with 5 rounds of intravenous immunoglobulin (IV Ig) (fresh antibodies). Patient was discharged to rehabilitation hospital on 01-MAY-2021 for rehab and recovery. Patient was discharged to home on 15-MAY-2021. Patient developed weakness and unable to function again. Patient was sent back to medical center on 09-JUN-2021, and did another lumbar puncture with elevated proteins. Patient was admitted again and treated with plasmapheresis (transfusion of plasma for fresh antibodies to get immune system to stop attacking his peripheral nervous system). Patient was there for 10 days and discharged again to rehabilitation hospital. Patient went through physical and occupational therapy for 10 days. Patient developed weakness again, and transferred back to medical center and did an electromyogram (EMG) test (to see extent of prevalent damage in his left leg). Patient developed a lot of numbness in hands and feet. Mid-section (waist) was numb, felt like wearing a "wrestling belt". Patient required assistance of walker. Patient was admitted once again to medical center on 19-JUN-2021, treated with intravenous (IV) steroids then oral prednisone, which he continued to be on. This was intended to knock down the lingering inflammation and allow him to regain the strength to the rehab once again. Patient was transferred again to rehabilitation hospital, on 29-JUN-2021. Patient returned to medical center on 01-JUL-2021 for another intravenous (IV) steroid and second electromyogram (EMG) test, then back to rehabilitation hospital on 03-JUL-2021. Finally patient was discharged to home on 13-JUL-2021 and continued with physical and occupational therapy home visits since. After successfully completing rehab work at rehabilitation hospital, and has been convalescing ever since. At the time of this report, patient continued to improve but was taking a long time. Patient body was regenerating and repairing the damage to the myelin sheath surrounding his axon nerves. Patient understands it will take time for him to improve, and still walks with assistance of walker and goes through physical and occupational therapy to regain balance. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from Guillain Barre syndrome, weakness, numbness in hands and feet, unable to function, lingering inflammation, and midsection (waist) was numb. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: This spontaneous report received from a patient concerned a 58-year-old white male who experienced Guillain Barre syndrome (GBS) 2 weeks after vaccine. No significant past medical history was reported. No concomitant medications were reported. Patient developed GBS two weeks post-vaccination and was hospitalized. His symptoms included numb mid-section of torso, fingertip numbness, aching feeling all over the torso and legs, "ants under skin" feeling, and facial palsy. The symptoms gradually spread and worsened over time with bilateral weakness and urinary urgency. COVID-19 virus test on an unspecified date was negative. Patient was admitted and underwent magnetic resonance imaging (MRI) and lumbar puncture and was diagnosed with GBS. Patient was treated with 5 rounds of intravenous immunoglobulin (IVIG). Patient was discharged to rehabilitation hospital on day 28 and discharged home on day 42. Patient developed weakness and was readmitted days 67-77, with another lumbar puncture with elevated proteins. Patient was treated with plasmapheresis and discharged to rehab. Patient developed weakness again, underwent electromyogram (EMG). Patient was admitted once again days 77-87, treated with intravenous (IV) steroids then oral prednisone, then returned to rehab. Patient returned to medical center on day 89 for another intravenous (IV) steroid and second electromyogram (EMG) test, then back to rehab on day 91. Finally, patient was discharged to home on day 101 and continued with physical and occupational therapy home visits since. At the time of this report, patient continued to improve, but slowly. Information regarding other potential etiologies was insufficient, and the occurrence of GBS could represent background incidence of such events in the general population. Considering the temporal relationship, the event is assessed to have an indeterminate relationship with vaccination.


VAERS ID: 1594399 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210835068

Write-up: GUILLAIN-BARRE SYNDROME; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown. The Company is unable to perform follow-up to request batch number) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced Guillain-Barre syndrome. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of Guillain-Barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: This spontaneous report received from a consumer via a company representative concerned a female of unspecified age who experienced Guillain Barre syndrome (GBS) an unknown time after vaccine. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced GBS. No other details regarding symptoms, diagnostics, treatment, or outcome were provided. Information is limited in this case, and the occurrence of GBS could represent background incidence of such events in the general population. Therefore, the relationship of GBS to vaccination is considered unclassifiable due to insufficient information. Additional information will be requested if contact information becomes available.


VAERS ID: 1602570 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-07-14
Onset:2021-07-18
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-08-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Electromyogram, Facial paralysis, Guillain-Barre syndrome, Muscular weakness, Nerve conduction studies
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: essential hypertension, anxiety
Allergies: NKA
Diagnostic Lab Data: STUDY TYPE: EMG/NCV FINDINGS: Left peroneal motor NCVs are undetectable. Right peroneal motor NCVs show amplitude which is 45% of normal minimal values, significantly prolonged distal latency, and markedly slowed conduction velocity in the distal segment. Left tibial motor distal latency is markedly prolonged, with normal amplitude but significant slowing in the conduction velocity. The right tibial motor distal latency is normal. Amplitude is 85% of normal minimal values, with significant slowing of the conduction velocity. Left sural sensory NCVs are normal. Right sural sensory NCVs are normal. Superficial peroneal sensory responses were not detected on either side. The left peroneal F-waves are not detectable, right peroneal F-waves are normal, but the tibial F-waves are significantly prolonged bilaterally. EMG needle examination of the left lower extremity is unremarkable including lumbar paraspinous muscles. IMPRESSION: This is an abnormal electromyography and nerve conduction velocity of the lower extremities revealing electrophysiologic evidence of: There is a generalized predominantly distal demyelinating motor polyneuropathy. Findings are consistent with Guillain-Barre syndrome, however, other demyelinating predominantly motor polyneuropathies could present in a similar fashion. Evidence of acute denervation is not demonstrated on this study, which in the case of Guillain-Barre/acute inflammatory demyelinating polyneuropathy, predicts a good prognosis for rapid recovery. Clinical correlation is advised.
CDC Split Type:

Write-up: Guillain-Barr? syndrome with facial diplegia and significant neuromuscular weakness without respiratory failure, requiring treatment with IVIG and steroids. Patient improved and is transferring to an acute neuro rehab today.


VAERS ID: 1623640 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-04-29
Onset:2021-07-30
   Days after vaccination:92
Submitted: 0000-00-00
Entered: 2021-08-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Asthenia, Autonomic nervous system imbalance, COVID-19, Cough, Diaphragm muscle weakness, Diarrhoea, Dyspnoea, Guillain-Barre syndrome, Hypertensive urgency, Intensive care, Nausea, Neurological symptom, Paraesthesia, Pneumonia, Pyrexia, Respiratory disorder, Respiratory muscle weakness, SARS-CoV-2 test positive, Vomiting
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypertension (narrow), Cardiomyopathy (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Noninfectious diarrhoea (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: unknown- at time of illness, taking cephalexin and omeprazole
Current Illness: unknown- Starting 7/21 respiratory illness, fever, diarrhea, nausea, neurological symptoms. Diagnosed with AIDP/Guillain-Barre Syndrome 8/3/21. Also, COVID positive, pneumonia, hypertensive urgency and dysautonomia.
Preexisting Conditions: obesity, borderline hypertension, OSA not on CPAP, and GERD
Allergies: tramadol- dizziness, HA and nausea Vit B complex- edema
Diagnostic Lab Data: unknown
CDC Split Type:

Write-up: Starting about 7/30/21 fever, emesis and diarrhea. Then developed dyspnea and cough. Then developed neurological symptoms including weakness, parasthesias, diaphragmatic and respiratory muscle involvement, hypertensive urgency and dysautonomia. Hospitalized at Neuro ICU.


Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=14&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166